NCT03941730 - Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 28, 2019

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Advanced Triple-Negative Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast CarcinomaRecurrent Breast Carcinoma

Interventions

PROCEDURE

Biopsy

Undergo tissue biopsy

PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography

Undergo PET

BIOLOGICAL

Therapeutic Estradiol

Given PO

Trial Locations (9)

10461

Montefiore Medical Center-Einstein Campus, The Bronx

20007

MedStar Georgetown University Hospital, Washington D.C.

35233

University of Alabama at Birmingham Cancer Center, Birmingham

55905

Mayo Clinic in Rochester, Rochester

60637

University of Chicago Comprehensive Cancer Center, Chicago

94158

UCSF Medical Center-Mission Bay, San Francisco

98109

FHCC South Lake Union, Seattle

98195

University of Washington Medical Center - Montlake, Seattle

32224-9980

Mayo Clinic in Florida, Jacksonville